Rituximab (chimeric anti-CD20 antibody) for posttransplant lymphoproliferative disorder after solid organ transplantation in adults: long-term experience from a single center. (Q51826613)
Jump to navigation
Jump to search
scientific article published in December 2005
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Rituximab (chimeric anti-CD20 antibody) for posttransplant lymphoproliferative disorder after solid organ transplantation in adults: long-term experience from a single center. |
scientific article published in December 2005 |
Statements
1 reference
Rituximab (chimeric anti-CD20 antibody) for posttransplant lymphoproliferative disorder after solid organ transplantation in adults: long-term experience from a single center. (English)
1 reference
John J Fung
1 reference
Ashokkumar B Jain
1 reference
Amadeo Marcos
1 reference
Renu Pokharna
1 reference
Ron Shapiro
1 reference
Paulo A Fontes
1 reference
Wallace Marsh
1 reference
Ravi Mohanka
1 reference
1 December 2005
1 reference
1 reference
80
1 reference
12
1 reference
1692-1698
1 reference
Identifiers
1 reference